6.
Wang X, Zhou M, Liu Y, Si Z
. Cope with copper: From copper linked mechanisms to copper-based clinical cancer therapies. Cancer Lett. 2023; 561:216157.
DOI: 10.1016/j.canlet.2023.216157.
View
7.
Wang Z, Jin D, Zhou S, Dong N, Ji Y, An P
. Regulatory roles of copper metabolism and cuproptosis in human cancers. Front Oncol. 2023; 13:1123420.
PMC: 10076572.
DOI: 10.3389/fonc.2023.1123420.
View
8.
Watson J
. Oxidants, antioxidants and the current incurability of metastatic cancers. Open Biol. 2013; 3(1):120144.
PMC: 3603456.
DOI: 10.1098/rsob.120144.
View
9.
Duda-Chodak A, Tarko T
. Possible Side Effects of Polyphenols and Their Interactions with Medicines. Molecules. 2023; 28(6).
PMC: 10058246.
DOI: 10.3390/molecules28062536.
View
10.
Farhan M, Zafar A, Chibber S, Khan H, Arif H, Hadi S
. Mobilization of copper ions in human peripheral lymphocytes by catechins leading to oxidative DNA breakage: A structure activity study. Arch Biochem Biophys. 2015; 580:31-40.
DOI: 10.1016/j.abb.2015.06.019.
View
11.
Whitlock N, Baek S
. The anticancer effects of resveratrol: modulation of transcription factors. Nutr Cancer. 2012; 64(4):493-502.
PMC: 3349800.
DOI: 10.1080/01635581.2012.667862.
View
12.
Arif H, Sohail A, Farhan M, Rehman A, Ahmad A, Hadi S
. Flavonoids-induced redox cycling of copper ions leads to generation of reactive oxygen species: A potential role in cancer chemoprevention. Int J Biol Macromol. 2017; 106:569-578.
DOI: 10.1016/j.ijbiomac.2017.08.049.
View
13.
Salehi B, Mishra A, Nigam M, Sener B, Kilic M, Sharifi-Rad M
. Resveratrol: A Double-Edged Sword in Health Benefits. Biomedicines. 2018; 6(3).
PMC: 6164842.
DOI: 10.3390/biomedicines6030091.
View
14.
Khan H, Zubair H, Faisal M, Ullah M, Farhan M, Sarkar F
. Plant polyphenol induced cell death in human cancer cells involves mobilization of intracellular copper ions and reactive oxygen species generation: a mechanism for cancer chemopreventive action. Mol Nutr Food Res. 2013; 58(3):437-46.
DOI: 10.1002/mnfr.201300417.
View
15.
Lin H, Tang H, Davis F, Davis P
. Resveratrol and apoptosis. Ann N Y Acad Sci. 2011; 1215:79-88.
DOI: 10.1111/j.1749-6632.2010.05846.x.
View
16.
Michno A, Gruzewska K, Ronowska A, Gul-Hinc S, Zysk M, Jankowska-Kulawy A
. Resveratrol Inhibits Metabolism and Affects Blood Platelet Function in Type 2 Diabetes. Nutrients. 2022; 14(8).
PMC: 9026466.
DOI: 10.3390/nu14081633.
View
17.
Howells L, Berry D, Elliott P, Jacobson E, Hoffmann E, Hegarty B
. Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases--safety, pharmacokinetics, and pharmacodynamics. Cancer Prev Res (Phila). 2011; 4(9):1419-25.
PMC: 3173869.
DOI: 10.1158/1940-6207.CAPR-11-0148.
View
18.
Rizvi A, Furkan M, Naseem I
. Physiological serum copper concentrations found in malignancies cause unfolding induced aggregation of human serum albumin in vitro. Arch Biochem Biophys. 2017; 636:71-78.
DOI: 10.1016/j.abb.2017.11.001.
View
19.
Patel K, Brown V, Jones D, Britton R, Hemingway D, Miller A
. Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res. 2010; 70(19):7392-9.
PMC: 2948608.
DOI: 10.1158/0008-5472.CAN-10-2027.
View
20.
Ge E, Bush A, Casini A, Cobine P, Cross J, DeNicola G
. Connecting copper and cancer: from transition metal signalling to metalloplasia. Nat Rev Cancer. 2021; 22(2):102-113.
PMC: 8810673.
DOI: 10.1038/s41568-021-00417-2.
View